Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo therapy aims to boost lung cancer fight before and after surgery

NCT ID NCT02572843

Completed Disease control Sponsor: Swiss Cancer Institute Source: ClinicalTrials.gov ↗

Summary

This study tested if adding a newer immunotherapy drug (MEDI4736) to standard chemotherapy could better control a specific type of lung cancer (stage IIIA). The treatment was given both before surgery (to shrink the tumor) and after surgery (to prevent it from coming back). The goal was to see if this combination was effective and safe for 68 patients with this operable lung cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CCAC Lausanne

    Lausanne, 1004, Switzerland

  • Centre hospitalier universitaire vaudois CHUV

    Lausanne, CH-1011, Switzerland

  • Hopital Cantonal Universitaire de Geneve

    Geneva, CH-1211, Switzerland

  • Hopital Fribourgeois HFR

    Fribourg, 1708, Switzerland

  • IOSI Ospedale Regionale di Bellinzona e Valli

    Bellinzona, 6500, Switzerland

  • Inselspital Bern

    Bern, CH-3010, Switzerland

  • Kantonsspital Aarau

    Aarau, CH-5001, Switzerland

  • Kantonsspital Baden

    Baden, 5404, Switzerland

  • Kantonsspital Graubuenden

    Chur, CH-7000, Switzerland

  • Kantonsspital St. Gallen

    Sankt Gallen, 9007, Switzerland

  • Kantonsspital Winterthur

    Winterthur, CH-8401, Switzerland

  • Klinik Hirslanden Onkozentrum Zürich

    Zurich, CH-8032, Switzerland

  • Luzerner Kantonsspital

    Lucerne, CH-6000, Switzerland

  • Regionalspital

    Thun, 3600, Switzerland

  • Spital Thurgau AG

    Frauenfeld, CH-8500, Switzerland

  • St. Claraspital Basel

    Basel, 4016, Switzerland

  • Stadtspital Triemli

    Zurich, Canton of Zurich, 8063, Switzerland

  • UniversitaetsSpital Zuerich

    Zurich, CH-8091, Switzerland

  • Universitaetsspital Basel

    Basel, 4031, Switzerland

Conditions

Explore the condition pages connected to this study.

NSCLC (NON-SMALL CELL LUNG CANCER)